Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





Current Intelligence Bulletin 20: Tetrachloroethylene (Perchloroethylene)										Related Pages
										January 20, 1978
DHHS (NIOSH) Publication Number

Synonyms
Ankilostin — NIOSH-RTECS KX28500
Antisal 1 — Tetracap
Cas 127-18-4 — Tetrachlorethylene
Didakene — Tetrachloroethene
Ethylene — tetrachloride Tetraguer
Fedal-Un — Tetraleno
Nema — Tetropil
Perclene — Tetlen
PerSec — 1,1,2,2-Tetrachloroethylene

Tetrachloroethylene (Perchloroethylene)
The National Institute for Occupational Safety and Health (NIOSH) recommends that it is prudent to handle tetrachloroethylene (perchloroethylene) in the workplace as if it were a human carcinogen. The recommendation is based on a recent study by the National Cancer Institute (NCI) indicating that tetrachloroethylene causes liver cancer in laboratory mice.1 This Bulletin is to advise you of the findings of the NCI study, other pertinent data, their implications for occupational health, and precautions for handling tetrachloroethylene.
Animal studies are valuable in helping identify human carcinogens. Substances that cause cancer in experimental animals must be considered to pose a potential cancer risk in man. Safe levels of exposure to carcinogens have not been demonstrated, but the probability of cancer development is lowered with decreasing exposure to carcinogens. Thus NIOSH recommends that occupational exposure to tetrachloroethylene be minimized and is providing suggested industrial hygiene practices. This is an interim recommendation while the carcinogenic potential of tetrachloroethylene in the workplace is being further evaluated.
The current Occupational Safety and Health Administration (OSHA) standard for occupational exposure to tetrachloroethylene is 100 ppm, (8-hour time-weighted average). In July 1976 NIOSH 3 recommended an exposure limit of 50 ppm (time-weighted average for up to a 10-hour workday, 40-hour workweek). Neither of these levels may provide adequate protection from potential carcinogenic effects because they were selected to prevent toxic effects other than cancer.

Potential Occupational Exposures
Tetrachloroethylene is a volatile liquid with an odor detectable at about 50 ppm. It is a solvent widely used in dry cleaning, fabric finishing, metal degreasing, and other applications. NIOSH estimates that approximately 500,000 workers are currently at risk of exposure to tetrachloroethylene in the United States. Over 20,000 dry cleaning establishments and a large number of other industries manufacture or use this substance. About 700 million pounds of tetrachloroethylene are currently produced in the United States each year.
Two-thirds of the domestically consumed tetrachloroethylene is used for dry cleaning and for the processing and finishing of textiles. Tetrachloroethylene is used by three-quarters of the dry cleaners in the United States because it is an excellent cleaner of most fabrics, is easily recycled, and is not flammable.
Metal cleaning accounts for approximately fifteen percent of the domestic consumption of tetrachloroethylene, where exposures can occur during degreasing and cold cleaning. Tetrachloroethylene also serves as a chemical intermediate in the synthesis of trichlorotrifluoroethane (fluorocarbon 113), dichlorotetrafluoroethane (fluorocarbon 114), chloropentafluoroethane (fluorocarbon 115), and hexafluoroethane (fluorocarbon 116). Tetrachloroethylene exposures may also occur in extraction processes, during its use as an industrial solvent, as a heat exchange fluid, and as a drug in treatment of internal parasite infestations.

Laboratory Animal Studies for Carcinogenicity
The long term animal study reported by NCI demonstrates tetrachloroethylene to be carcinogenic in laboratory mice. In the study, B6C3F1 mice were force fed tetrachloroethylene for 78 weeks. Male mice were treated at two dose levels (536 or 1072 mg/kg/day) and female mice were treated at two different dose levels (386 or 772 mg/kg/day). A significant increase of hepatocellular carcinoma (liver cancer) was observed in both sexes of treated mice when compared with control animals. At both dose levels more than 50% of the male mice and 40% of the female mice (each from groups of approximately 50 animals) developed liver cancer. By comparison, cancer developed in 12% or less of the groups of untreated or vehicle-matched controls. This NCI report is the first definitive association of tetrachloroethylene with cancer. To relate some of the above information to the work environment a 70 kg man breathing a typical 10 cu m/day (over an 8-hour work shift) of air contaminated with 100 ppm of tetrachloroethylene would have an inhalation exposure of about 100 mg/kg/day.
In the same NCI report, Osborne-Mendel rats showed no significant increase of liver cancer under the same experimental procedure. Because many of the rats died early in the study, this bioassay was considered inadequate for the carcinogenicity testing of tetrachloroethylene. However there was a high incidence of kidney damage observed in both the rats and mice treated with tetrachloroethylene.
A study by The Dow Chemical Company 2 found many tumors in Sprague-Dawley rats exposed by inhalation to 300 or 600 ppm tetrachloroethylene, but for most tumors there was no statistically significant difference in tumor incidence between exposed and control rats. Some tumors were found in higher incidence in control animals. The only tumor seen at higher incidence in exposed animals was adrenal pheochromocytoma in female rats at the lower exposure level only. Pheochromocytoma is a tumor which gives rise to high blood pressure and hyperglycemia due to release of adrenalin and noradrenalin into the blood. Increased mortality occurred in male rats exposed to 600 ppm tetrachloroethylene.
Section references: 1,2

Other Laboratory Animal Studies
The liver is a principal target organ of tetrachloroethylene exposure in animals. Typical toxic effects are fatty liver) liver enlargement and abnormal liver function tests, Tetrachloroethylene has also been shown to cause kidney damage in mice following intraperitoneal injection and in rats and rabbits following inhalation.
Neurophysiological effects of tetrachloroethylene are reflected in the distinct alterations of the electroencephalogram (EEG) in rats. Central nervous system (CNS) depression including abnormal weakness, handling intolerance intoxication, restlessness, irregular respiration, muscle incoordination, and unconsciousness have been observed in exposed animals.
Tetrachloroethylene has been shown to be a primary eye and skin irritant in rabbits. Other effects of tetrachloroethylene exposure in laboratory animals include lung damage (excessive fluid accumulation inflammation, congestion, or hemorrhage, cardiac depression, decreased blood pressure depressed respiration, decreased oxygen consumption, and depression in growth rate.
One study suggests the teratogenic potential of tetrachloroethylene. Fetal and maternal toxicity was observed in mice and rats exposed to tetrachloroethylene on days 615 of gestation. In this study a decrease in the maternal weight gain in rats, an increase in the relative weight of the liver in pregnant mice, an increase of fetal reabsorption in rats, a decrease in fetal body weight and an increase of subcutaneous edema in fetal mice, were all associated with exposure to tetrachloroethylene. Delayed ossification of skull bones and split sternebrae were possible teratogenic effects observed in mice.
Section references: 3,5,6,7,8,13

Human Toxicity
Clinical evidence accumulated over the years clearly demonstrates that tetrachloroethylene is toxic to the liver and kidneys in humans. Liver impairment has been noted in cases of exposure to tetrachloroethylene as evidenced by abnormal liver function tests. Also, toxic chemical hepatitis, and enlargement of the liver and spleen have been associated with exposure to tetrachloroethylene. Tetrachloroethylene vapor is irritating to the eyes and upper respiratory tract, and may cause frontal sinus congestion and headache. Direct contact with skin can cause burns, blistering, and erythema due to the “degreasing” effect of tetrachloroethylene on the skin. Over a period of time this can result in extreme skin dryness with cracking and associated infection.
Altered physiological and behavioral responses observed in subjects exposed to tetrachloroethylene include vague nonspecific complaints generally attributed to CNS depression. These symptoms include vertigo, impaired memory, confusion fatigue drowsiness irritability loss of appetite nausea and vomiting. Motor coordination following tetrachloroethylene exposure requires additional mental effort, which along with memory impairment and fatigue have important implications for worker safety. Various disturbances of the peripheral nervous system such as tremors and numbness have also been associated with exposure to tetrachloroethylene. Excessive absorption of tetrachloroethylene can cause severe depression of the CNS leading to coma; ultimately death may occur from respiratory paralysis or circulatory failure.
Tetrachloroethylene is most commonly absorbed through the lungs and can be absorbed from the intestines if ingested. The skin is a less important absorption site. Physical exercise can significantly increase the amount of tetrachloroethylene absorbed through the lungs because of greater respiration and increased blood flow.
Metabolism and elimination of tetrachloroethylene is relatively slow. It is deposited in body fat and the biologic halflife of tetrachloroethylene in man is estimated at six days.
Section references: 3,4,8,9,10,11,12,14

NIOSH Action on Tetrachloroethylene
NIOSH has contracted for a retrospective mortality study of persons employed in dry cleaning establishments where there had been exposure to tetrachloroethylene. The contract will be monitored by the Biometry Section of the NIOSH Industry-wide Studies Branch.
The NIOSH Industrial Hygiene Section of the Industry-wide Studies Branch plans an industrial hygiene assessment of dry cleaning workers exposed to tetrachloroethylene.
The NIOSH Behavioral and Motivational Factors Branch is undertaking a tetrachloroethylene behavioral teratology study. The study results should be available in late 1978.
NIOSH has contracted for a control technology assessment of the dry cleaning industry. The contract will be monitored by the NIOSH Control Technology Research Branch.
NIOSH will coordinate research on tetrachloroethylene with the National Cancer Institute (NCI) which is also examining the mortality experience of persons employed in dry cleaning establishments.
NIOSH has contracted for a study to evaluate the potential teratogenicity and the mutagenicity of tetrachloroethylene. This contract will be monitored by the NIOSH Experimental Toxicology Branch.
Currently available NIOSH publications on tetrachloroethylene include:
Criteria for a recommended standard .... Occupational Exposure to Tetrachloroethylene (Perchloroethylene). HEW Publication No. (NIOSH) 76-185.
Health and Safety Guide for Laundries and Dry Cleaners. HEW Publication No. (NIOSH) 75-151.
Effects of Perchloroethylene/Drug Interaction on Behavior and Neurological Function HEW Publication No. (NIOSH) 77-124 191.
A Behavioral and Neurological Evaluation of Dry Cleaners Exposed Perchloroethylene. HEW Publication No. (NIOSH) 77-214.*[signature]*
Edward J. Baier
Deputy Director

Suggested Procedures for Minimizing Employee Exposure to Etrachloroethylene (Perchloroethylene)

Control of Overexposures
NIOSH recommends that it is prudent to handle tetrachloroethylene in the workplace as if it were a human carcinogen and that occupational exposure to tetrachloroethylene be minimized. Exposure to tetrachloroethylene should be limited to as few employees as possible while minimizing workplace exposure levels. The area in which it is used should be restricted to those employees necessary to the process or operation. Furthermore, consideration should be given to isolating the tetrachloroethylene exposure area so that adjacent workers are not also exposed.
**Exposure monitoring**
The *NIOSH Occupational Exposure Sampling Strategy Manual,* NIOSH publication #77-173, may be helpful in developing efficient programs to monitor employee exposures to tetrachloroethylene. The manual discusses determination of the need for exposure measurements, selection of appropriate employees for sampling, and selection of sampling times.
Employee exposure measurement samples can be obtained and analyzed using the guidelines in NIOSH method #P&CAM l27 in the second edition of the *NIOSH Manual of Analytical Methods,* NIOSH publication #77-157. Exposure measurements should consist of 8-hour TWA exposure estimates calculated from personal or breathing zone samples (air that would most nearly represent that inhaled by the employees).
**Engineering controls**
Engineering and work practice controls should be used to minimize employee exposure to tetrachloroethylene.
To ensure that ventilation equipment is working properly, it is advised that effectiveness be checked at least every three months (e.g., air velocity, static pressure or air volume). System effectiveness should also be checked within five days of any change in production, process, or control which might result in significant increases in airborne exposures to tetrachloroethylene.
**Respiratory protection**
Exposure to tetrachloroethylene should not be controlled with the use of respirators except:
During the time period necessary to install or implement engineering or work practice controls; or
In work situations in which engineering and work practice controls are technically not feasible; or
To supplement engineering and work practice controls when such controls fail to adequately control exposure to tetrachloroethylene; or
For operations which require entry into tanks or closed vessels; or
In emergencies.Respirators should be approved by the National Institute for Occupational Safety and Health (NIOSH) or by the Mining Enforcement and Safety Administration (MESA). Refer to *NIOSH Certified Equipment, December 15, 1975,* NIOSH publication #76-145 and *Cumulative Supplement June 1977, NIOSH Certified Equipment,* NIOSH Publication #77-195. The use of face seal coverlets or socks with any respirator voids NIOSH/MESA approvals.
Quantitative faceseal fit test equipment (such as sodium chloride or PDOP) should be used. Refer to A Guide to Industrial Respiratory Protection, NIOSH publication #76-189 for guidelines on appropriate respiratory protection programs.
Where respirators are used under the preceding guidelines, NIOSH recommends that for routine use the employer provide either a) Self-contained breathing apparatus with a full facepiece operated in pressure-demand for other positive pressure mode (30 CFR 11.70(a)) or b) A combination respirator which includes a Type-C supplied-air respirator with a full facepiece operated in pressure-demand or other positive pressure or continuous flow mode and an auxiliary self-contained breathing apparatus operated in pressure-demand or positive pressure mode (30 CFR 11.70(b)). For firefighting, the employer should provide a) Self-contained breathing apparatus with a full facepiece operated in pressure-demand or other positive pressure mode (30 CFR 11.70(a)). For escape the employer should provide a) Any gas mask providing protection against organic vapors (30 CFR 11.90) or b) Any escape self-contained breathing apparatus (30 CFR 11.70(a)).

Personal Protective Equipment
Employers should provide impervious, gloves, face shields (8-inch minimum) and other appropriate clothing necessary to prevent repeated or prolonged skin contact with liquid tetrachloroethylene.
Employers should see that employee clothing wet with liquid tetrachloroethylene is placed in closed containers for storage until it can be discarded or until the employer provides for the removal of tetrachloroethylene from the clothing. If the clothing is to be laundered or otherwise cleaned to remove the tetrachloroethylene, the employer should inform the person performing the operation of the hazardous properties of tetrachloroethylene including the fact that it is a possible human carcinogen.
Employers should see that permeable clothing which becomes contaminated with liquid tetrachloroethylene be removed promptly and not reworn until the tetrachloroethylene is removed from the clothing.

Personal Hygiene
Employers should see that employees who handle liquid tetrachloroethylene wash their hands thoroughly with soap or mild detergent before eating, smoking or using toilet facilities.
Employers should see that employees whose skin becomes contaminated with liquid tetrachloroethylene promptly wash or shower with soap and mild detergent and water to remove any tetrachloroethylene from the skin.

Bibliography
Bioassay of Tetrachloroethylene for Possible Carcinogenicity, DHEW Publication No. (NIH) 77-813. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, October, 1977.
Rampy, L. W., J. F. Quast, B.K.J. Leong and P.J. Gehring, Results of longterm inhalation toxicity studies on rats of 1,1, trichloroethane and perchloroethylene formulations. Toxicology Research Laboratory, Dow Chemical, U.S.A., Poster presentation International Congress of Toxicology, Toronto, Canada, April, 1977.
Criteria for a recommended standard .... Occupational Exposure to Tetrachloroethylene (Perchloroethylene). HEW Publication No. (NIOSH) 76-185. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, July, 1976.
Fishbein, L., Industrial mutagens and potential mutagens I. Halogenated aliphatic derivatives. Mutat. Res., 32: 267-308, 1976.
Fujii, T., Variation in the liver function of rabbits after administration of chlorinated hydrocarbons, Jap. J. Ind. Hlth., 17: 81-88, 1975.
Duprat, P., L. Delsaut and D. Gradiski, Irritant potency of the principal aliphatic chloride solvents on the skin and ocular mucous membranes of rabbits. Europ. J. Toxicol., 3: 171-177, 1976.
Brancaccio, A., V. Mazza and R. Di Paolo, Renal function in experimental tetrachloroethylene poisoning. Folia Med., 54: 233-237, 197l.
Mazza, V., Enzymatic changes in experimental tetrachloroethylene poisoning. Folia Med., 55: 373-381, 1972.
Korn, J., How many more? Perchloroethylene intoxication in coin drycleaning establishments. Ugeskr. laeg., 139: 303-304, 1977.
Weichardt, H., and J. Lindner, Health hazards due to perchloroethylene in chemical drycleaning enterprises from the viewpoint of occupational medicine and toxicology. Staub Reinhalt Luft, 35: 416-420, 1975.
Medek, V., and J. Kovarik, The effect of perchloroethylene on the health of workers. Pracovni lekarstvi, 25: 339-341, 1973.
Larsen, N. B. Nielsen, and A. RaynNielsen, Perchloroethylene intoxication. A hazard in the use of coin laundries. Ugeskr. Laeg., 139: 270-275, 1977.
Schwetz, B.A., KJ. Leong and P.J. Gehring, The effect of maternally inhaled trichloroethylene, perchloroethylene, methyl chloroform and methylene chloride on embryonal and fetal development in mice and rats. Toxicol. Appl. Pharmacol., 32: 84-96, 1975.
Ikeda, M., and T. Imamura, Biological halflife of trichloroethylene and tetrachloroethylene in human subjects. Int. Arch. Arbeitsmed., 31: 209-224) 1973.
							
					
						Page last reviewed:  June 6, 2014					Content source: 	National Institute for Occupational Safety and Health homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue